Login/Sign Up
Etacept PFS 25 mg Injection 0.5 ml
Etacept PFS 25 mg Injection 0.5 ml is used to treat Rheumatoid arthritis, Ankylosing spondylitis, Psoriatic arthritis, and Plaque psoriasis. It contains Etanercept, which works by blocking the effects of TNF-alpha, a pro-inflammatory cytokine that becomes elevated in psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. Common side effects of this medication include tingling or numbness, dizziness, shortness of breath, bleeding, pale skin, bruising, vision problems, redness on the skin and arms, and injection site reactions.
₹2870*
MRP ₹3500
18% off
₹2975*
MRP ₹3500
15% CB
₹525 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Etacept PFS 25 mg Injection 0.5 ml is an immunosuppressant medicine that helps reduce signs and symptoms of autoimmune disorders. It is primarily used in the treatment of rheumatoid arthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, and plaque psoriasis. Etacept PFS 25 mg Injection 0.5 ml is generally used alone or in combination with methotrexate medicine.
Etacept PFS 25 mg Injection 0.5 ml consists of Etanercept, which belongs to the TNF (Tumor necrosis factor) inhibitor class of drugs. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain caused due to various autoimmune diseases.
Etacept PFS 25 mg Injection 0.5 ml may cause certain side effects such as tingling or numbness, dizziness, shortness of breath, bleeding, pale skin, bruising, vision problem, redness on the skin and arms, and injection site reactions. Most of these side effects do not require medical attention or resolve over time. However, if these side effects persist for longer, please consult your doctor on priority. Etacept PFS 25 mg Injection 0.5 ml is a parenteral medicine. It will be administered by a trained healthcare doctor. Hence, do not self-administer. Your physician will decide the dose and duration of the medicine based on the type and severity of the condition.
Etacept PFS 25 mg Injection 0.5 ml should be avoided if allergic to it or any other components present. Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, Hepatitis B Virus infection, heart failure, liver, heart, or kidney diseases, or a weak immune system, as it can worsen your health condition. Etacept PFS 25 mg Injection 0.5 ml may cause dizziness, so drive only if you are alert and focused. Etacept PFS 25 mg Injection 0.5 ml should not be given to children under two years of age as safety has not been established. Avoid consuming alcohol along with Etacept PFS 25 mg Injection 0.5 ml as it could lead to increased dizziness and risk of liver damage. Etacept PFS 25 mg Injection 0.5 ml is not recommended for use in pregnant and nursing mothers as it can cause serious adverse effects on the baby.
Etacept PFS 25 mg Injection 0.5 ml consists of Etanercept, which belongs to TNF (Tumor necrosis factor) inhibitor class of drugs. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce pain, redness, and inflammation (swelling) in patients with rheumatoid arthritis, ankylosing spondylitis, and other autoimmune disorders.
Etacept PFS 25 mg Injection 0.5 ml should be avoided if allergic to it or any other components present. Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, Hepatitis B Virus infection, heart failure, liver, heart or kidney diseases, weak immune system, multiple sclerosis (nerve and muscle disease), and diabetes as it can worsen your health condition. Do not take live vaccines while being treated with Etacept PFS 25 mg Injection 0.5 ml to prevent any serious consequences. Etacept PFS 25 mg Injection 0.5 ml may cause dizziness and drowsiness, so drive only if you are alert and focused. Avoid consuming alcohol along with Etacept PFS 25 mg Injection 0.5 ml as it could lead to increased dizziness and risk of stomach bleeding/ulcers. Etacept PFS 25 mg Injection 0.5 ml is not recommended for use in children below two years of age as safety and efficacy is not established. This medicine is not recommended for patients suffering from sepsis as it can worsen the condition.
Drug-Drug Interaction: Etacept PFS 25 mg Injection 0.5 ml may interact with other immunosuppressants (certolizumab, golimumab, infliximab, adalimumab, rituximab), medicines used to treat rheumatoid arthritis (anakinra), blood thinners (warfarin), cholesterol-lowering drugs (atorvastatin, lovastatin, simvastatin), acidity treating medicines (omeprazole), cough suppressants (Dextromethorphan), live vaccines, Alkylating agents (cyclophosphamide) and birth control pills.
Drug-Food Interaction: Alcohol consumption may cause dizziness and increase bleeding risk and liver injury.
Drug-Disease Interaction: Etacept PFS 25 mg Injection 0.5 ml should be used with caution in liver or kidney disease cases, heart failure, multiple sclerosis, diabetes, weak immune system (HIV), hepatitis B, cancer, and serious infections.
Rheumatoid arthritis: It is an auto-immune disease (the body's immune system attacks its tissue) that causes joint pain and damage. It occurs when the immune system does not work properly. Symptoms of rheumatoid arthritis include pain, swelling, stiffness, deformities and loss of joint function.
Ankylosing spondylitis: It causes pain and stiffness in the spine. The pain generally starts in the lower back and can spread to the neck, damaged joints, or other body parts. Ankylosing spondylitis symptoms include decreased flexibility which usually leads to a hunched-forward posture and pain in the back and joints.
Psoriatic arthritis: It is a type of inflammatory arthritis which occurs in patients with psoriasis. It could also occur in patients without psoriasis, particularly in those with a family history of psoriasis. It affects large joints in the lower extremities, the distal joints of toes and fingers, and the back and pelvis. Symptoms include inflammation of joints, difficulty moving, swelling, patches of red, scaly skin and pain.
Alcohol
Unsafe
Avoid alcohol consumption as alcohol intake, along with Etacept PFS 25 mg Injection 0.5 ml, may cause increased dizziness and risk of stomach bleeding/ulcers.
Pregnancy
Unsafe
It is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant, or planning pregnancy inform your doctor before receiving Etacept PFS 25 mg Injection 0.5 ml. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Unsafe
It is not recommended for use in breastfeeding as it may pass in to breast milk and harm your infant. Hence, if you are breastfeeding, inform your doctor before receiving Etacept PFS 25 mg Injection 0.5 ml. Your doctor may suggest you to stop feeding while on treatment with this medicine
Driving
Unsafe
Etacept PFS 25 mg Injection 0.5 ml may make you feel dizzy and sleepy. Do not drive or operate machinery if you experience dizziness or drowsiness.
Liver
Caution
Etacept PFS 25 mg Injection 0.5 ml should be used with caution if you have liver disease. Dose adjustment may be needed in patients with liver impairment. However, Etacept PFS 25 mg Injection 0.5 ml is not recommended in patients with active liver diseases.
Kidney
Caution
Etacept PFS 25 mg Injection 0.5 ml should be used with caution if you have kidney impairment. Dose adjustment may be needed in patients with liver impairment.
Children
Caution
Etacept PFS 25 mg Injection 0.5 ml is not recommended in children below two years of age as the safety and efficacy is not established. In children above two years of age, it will be administered by the paediatrician.
Country of origin
Manufacturer/Marketer address
Product Substitutes